Description
Aniracetamisanootropicampakinethatexhibitsanxiolyticandneuroprotectiveactivities.AniracetamactsasapositiveallostericmodulatorofAMPAreceptors,slowingreceptordeactivation;italsoactsonD2receptors,5-HT2Areceptors,andnicotinicacetylcholinereceptors(nAChRs),likelydisplayingagoNISTactivity.Aniracetamdecreasesanxietyinvivointheconditionfearstresstest,elevatedplusmazetest,andinsocialinteractiontests.Additionally,thiscompoundinhibitsH2O2-induceddeficitsinlong-termpotentiationandneuronviABIlity.AniracetamshowssomeclinicalbenefitintheenhancementofcognitivedeficitsassociatedwithstrokeandAlzheimer’sdisease.
References
WangYF,LiCC,CaiJX.AniracetamattenuatesH2O2-induceddeficiencyofneuronviability,mitochondriapotentialandhippocampallong-termpotentiationofmiceinvitro.NeurosciBull.2006Sep;22(5):274-80.PMID:17690727.
JinR,ClarkS,WeeksAM,etal.MechanismofpositiveallostericmodulatorsactingonAMPAreceptors.JNeurosci.2005Sep28;25(39):9027-36.PMID:16192394.
NakamuraK.Aniracetam:itsnoveltherapeuticpotentialincerebraldysfunctionaldisordersbasedonrecentpharmacologicaldiscoveries.CNSDrugRev.2002Spring;8(1):70-89.PMID:12070527.
NakamuraK,KurasawaM.Anxiolyticeffectsofaniracetaminthreedifferentmousemodelsofanxietyandtheunderlyingmechanism.EurJPharmacol.2001May18;420(1):33-43.PMID:11412837.
ItoI,TanabeS,KohdaA,etal.Allostericpotentiationofquisqualatereceptorsbyanootropicdruganiracetam.JPhysiol.1990May;424:533-43.PMID:1975272.
